Cable Hill Partners’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Other funds holding AXSM
RA
SCM
OPPM
ACM
BCM
Cable Hill Partners's AXSM Position: Q1 2018 in Review
Cable Hill Partners sold out of Axsome Therapeutics (AXSM) in Q1 2018, closing a stake of 1,000 shares — an estimated $6K sold.
Cable Hill Partners first reported a position in AXSM in Q3 2017 and held it in 2 quarters. The position peaked at $6K in Q4 2017. 36 funds tracked by Wall St. Rank hold AXSM as of Q1 2018.
- Cable Hill Partners reported no remaining Axsome Therapeutics position as of Q1 2018 after selling out during the quarter.
- Cable Hill Partners sold 1,000 Axsome Therapeutics shares in Q1 2018, an estimated $6K.
- Cable Hill Partners first reported a position in Axsome Therapeutics in Q3 2017 and held it in 2 quarters.
- Cable Hill Partners's Axsome Therapeutics position peaked at $6K in Q4 2017.
- 36 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2018.
Based on Cable Hill Partners's 13F filing for Q1 2018, filed 20 Apr 2018.